首页> 美国卫生研究院文献>Cell Death Disease >The MLKL kinase-like domain dimerization is an indispensable step of mammalian MLKL activation in necroptosis signaling
【2h】

The MLKL kinase-like domain dimerization is an indispensable step of mammalian MLKL activation in necroptosis signaling

机译:MLK1激酶样结构域二聚化是哺乳动物MLKL活化的不可或缺的粪便信号传导步骤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A Gel filtration analysis of purified recombinant human MLKL kinase-like domain (KLD) proteins on Superdex 75. The elution fractions were applied to SDS-PAGE followed by Coomassie blue staining. The elution positions of size standards are indicated (BSA, 67 kDa; Ovalbumin, 44 kDa; ribonuclease A, 14 kDa). B Detection of self-assembly of recombinant human MLKL kinase-like domain proteins using chemical crosslinker. Aliquots of purified recombinant wild-type or mutant forms of MLKL KLD proteins were mixed with DMSO or crosslinker DSG as described in the MATERIALS AND METHODS, Samples were subjected to SDS-PAGE and stained by Coomassie blue. Abbreviations are as follows: DSG, disuccinimidyl glutarate; WT, wild-type; AA, phosphor-sites’ mutant, T357A/S358A; ED, phosphomimic mutant, T357E/S358D. C Two perpendicular views of the overall structure of the phosphomimic mutant (T357E/S358D) of human MLKL kinase-like domain homodimer (green and cyan). All structural figures were prepared with PyMOL. D Structural comparison of the phosphomimic mutant (T357E/S358D) of human MLKL kinase-like domain homodimer (green and cyan) with the complex structure of mouse MLKL kinase-like domain (bluewhite) and mouse RIP3 kinase domain (brown) (PDB: 4M69). E Structural comparison of the phosphomimic mutant (T357E/S358D) of human MLKL kinase-like domain homodimer (green and cyan) with the full-length structure of mouse MLKL (palecyan, PDB: 4BTF).
机译:纯化的重组人MLKL的凝胶过滤分析激酶样结构域(KLD)蛋白在Superdex 75的级分进行SDS-PAGE,随后进行考马斯蓝染色的洗脱。的大小标准品的洗脱位置表示(BSA,67 kDa的;卵清蛋白,44kDa的;核糖核酸酶A,14 kDa的)。自组装的重组人MLKL的乙检测激酶样使用化学交联剂域的蛋白质。如在材料和方法中描述的纯化的重组野生型或MLKL KLD蛋白的突变体形式的等分试样与DMSO或交联剂DSG混合,对样品进行SDS-PAGE和考马斯亮蓝染色。缩写如下:DSG,二琥珀酰亚胺基戊二酸酯; wt,野生型; AA,荧光体的网站的突变体,T357A / S358A; ED,phosphomimic突变,T357E / S358D。 C两个垂直视图的phosphomimic突变体(T357E / S358D)的人类MLKL的整体结构的激酶样结构域同源二聚体(绿色和青色)。所有结构图用PyMOL的准备。人类MLKL的d结构的phosphomimic突变体(T357E / S358D)的比较激酶样结构域同源二聚体与小鼠MLKL的复杂结构(绿色和青色)激酶样结构域(bluewhite)和小鼠RIP3激酶结构域(褐色)(PDB: 4M69)。人类MLKL的phosphomimic突变体(T357E / S358D)电子结构比较激酶样结构域同源二聚体(绿色和青色)与小鼠MLKL(palecyan,PDB:4BTF)的全长结构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号